| 1 |
34620694 | Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical Recommendations. | 2022 Jan |
1 |
| 2 |
30991038 | Rifampin Induces Expression of P-glycoprotein on the THP1 Cell-Derived Macrophages, Causing Decrease Intramacrophage Concentration of Prothionamide. | 2019 Sep |
1 |
| 3 |
25159828 | Determination of fexofenadine in Hank's balanced salt solution by high-performance liquid chromatography with ultraviolet detection: application to Caco-2 cell permeability studies. | 2015 Apr |
1 |
| 4 |
27128001 | The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans. | 2015 Jan |
1 |
| 5 |
23976943 | Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp. | 2013 |
1 |
| 6 |
21443601 | Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. | 2011 Apr |
1 |
| 7 |
21459122 | Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. | 2011 Jul 11 |
2 |
| 8 |
21725799 | Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer. | 2011 Sep |
1 |
| 9 |
19816852 | Development and validation of RP-HPLC-fluorescence method for quantitative determination of quinidine, a probe substrate for P-glycoprotein inhibition assay using Caco-2 cell monolayer. | 2010 Jun |
1 |
| 10 |
17142564 | Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys. | 2007 Mar |
1 |
| 11 |
15887485 | Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors. | 2005 Apr 29 |
1 |
| 12 |
14670744 | Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates. | 2004 Jan 25 |
3 |